Economic analysis and outcome assessment of clinical breast examination and mammography screening for breast cancer detection among women in Klang, Selangor / Sophia Mohd Ramli
Breast cancer is the most common cause of cancer death among women in Malaysia. Screening for breast cancer are by opportunistic clinical breast examination (CBE) followed by mammogram if breast abnormality is detected, and by mammography screening among women with risk factors. An increasing numb...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://studentsrepo.um.edu.my/10366/ http://studentsrepo.um.edu.my/10366/4/sophia.pdf |
| Summary: | Breast cancer is the most common cause of cancer death among women in Malaysia. Screening for breast cancer are by opportunistic clinical breast
examination (CBE) followed by mammogram if breast abnormality is detected, and by
mammography screening among women with risk factors. An increasing number of
developed countries recommend mammogram screening in the general population. This
study aimed to compare economic aspects and outcome of CBE followed by
mammogram when breast abnormality is detected, and mammogram only among
women with risk factors in Selangor, Malaysia.
Methodology: This was an economic analysis and outcome assessment on breast
cancer screening comparing CBE followed by mammogram when abnormality is
detected, and mammogram only among women with risk factors. The costs were
calculated from the provider‘s perspective which was the Ministry of Health Malaysia.
Cost items were identified and measured using micro costing applying the activity based
costing approach. The output for cost analysis was cost per breast cancer screening. The
outcome measured was the number and rate of breast cancer detected. Cost per breast
cancer detected was also calculated for each breast cancer screening approach. To
calculate outcome of CBE followed by mammogram when abnormality is detected,
records of 15,279 women who came to the health clinics for Pap smear screening and
CBE were reviewed. Outcome of mammography only among women with risk factors
were obtained by reviewing 1,427 records of women attending the mammography
screening in a general hospital. The breast cancer status was ascertained from the
Selangor Breast Cancer Registry.
Results: The cost of CBE and mammography were RM 6.68 (USD 2.11;
1USD=RM3.17) and RM 197.30 (USD 62.26) per screening, respectively. Largest
iv
proportion of cost of CBE was contributed by cost of staff (61.1%), followed by cost of
utilities and communication (20.1%). For cost of mammography, majority was
contributed by cost of equipment and furniture (57.0%), followed by cost of staff
(29.0%). The rate of breast abnormality detected by CBE was 0.55% (84 women) of
which 0.07% (10 women) had breast cancer. For mammography among women with
risk factors, abnormality rate was 4.7% (67 women) of which 2.0% (29 women) had
breast cancer. Among breast cancer cases detected, 3 (30.0%) women were detected
early (stage 1&2), while 7 (70.0%) detected late (stage 3&4) for CBE followed by
mammography when breast abnormality detected, while for mammography among
women with risk factors, 10 (34.5%) women were in early stage, while 19 (65.5%) were
in late stage. Cost per breast cancer detected (excluding treatment costs) for CBE
followed by mammogram when abnormality is detected, and of mammogram among
women with risk factors were RM 11,864 (USD3, 744) and RM 9,709 (USD 3,064),
respectively.
Conclusion: The current practice of CBE followed by mammography when
abnormality is detected, and mammogram of women with risk factors should be
strengthened as the costs of breast cancer detection were relatively cheap. Efforts should
be focused on improving the participation rate for CBE and increasing the budget
allocation for mammogram for women with breast abnormality and risk factors of breast
cancer. |
|---|